Advertisement
TFX vs TNDM
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TFX is a StrongBuy and TNDM is a StrongBuy.
TFX in upward trend: price rose above 50-day moving average on October 22, 2026
TFX moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend. In 24 of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 63%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on TFX as a result. In 48 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 58%.
The Moving Average Convergence Divergence (MACD) for TFX just turned positive on October 01, 2026. Looking at past instances where TFX's MACD turned positive, the stock continued to rise in 32 of 51 cases over the following month. The odds of a continued upward trend are 63%.
Following a +5.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where TFX advanced for three days, in 165 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TFX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
TFX broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TFX entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.992) is normal, around the industry mean (4.961). P/E Ratio (-5.925) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.165) is also within normal values, averaging (4.143). Dividend Yield (0.010) settles around the average of (0.005) among similar stocks. P/S Ratio (2.508) is also within normal values, averaging (56.876).
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. TFX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TFX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
TNDM's RSI Oscillator ascends from oversold territory
The RSI Oscillator for TNDM moved out of oversold territory on September 25, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 47 similar instances when the indicator left oversold territory. In 43 of the 47 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on TNDM as a result. In 60 of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for TNDM just turned positive on October 02, 2026. Looking at past instances where TNDM's MACD turned positive, the stock continued to rise in 34 of 42 cases over the following month. The odds of a continued upward trend are 81%.
Following a +1.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where TNDM advanced for three days, in 211 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 50-day moving average for TNDM moved below the 200-day moving average on October 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TNDM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
TNDM broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TNDM entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. TNDM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.152) is normal, around the industry mean (2.874). P/E Ratio (-19.056) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (9.850) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.150) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TNDM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
TFX | TNDM | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 13 | 27 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 16 Undervalued | 92 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 98 | |
PRICE GROWTH RATING 1..100 | 50 | 60 | |
P/E GROWTH RATING 1..100 | 97 | 34 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TFX's Valuation (16) in the Medical Specialties industry is significantly better than the same rating for TNDM (92). This means that TFX’s stock grew significantly faster than TNDM’s over the last 12 months.
TFX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as TNDM (100). This means that TFX’s stock grew similarly to TNDM’s over the last 12 months.
TFX's SMR Rating (97) in the Medical Specialties industry is in the same range as TNDM (98). This means that TFX’s stock grew similarly to TNDM’s over the last 12 months.
TFX's Price Growth Rating (50) in the Medical Specialties industry is in the same range as TNDM (60). This means that TFX’s stock grew similarly to TNDM’s over the last 12 months.
TNDM's P/E Growth Rating (34) in the Medical Specialties industry is somewhat better than the same rating for TFX (97). This means that TNDM’s stock grew somewhat faster than TFX’s over the last 12 months.
| TFX | TNDM | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 71% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 68% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 58% | 1 day ago 81% |
| MACD ODDS (%) | 1 day ago 63% | 1 day ago 81% |
| TrendWeek ODDS (%) | 1 day ago 53% | 1 day ago 77% |
| TrendMonth ODDS (%) | 1 day ago 52% | 1 day ago 86% |
| Advances ODDS (%) | 7 days ago 58% | 3 days ago 78% |
| Declines ODDS (%) | 9 days ago 71% | 15 days ago 86% |
| BollingerBands ODDS (%) | 1 day ago 82% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 71% | 1 day ago 86% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
TFX’s FA Score shows that 1 FA rating(s) are green while TNDM’s FA Score has 0 green FA rating(s).
- TFX’s FA Score: 1 green, 4 red.
- TNDM’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
TFX’s TA Score shows that 4 TA indicator(s) are bullish while TNDM’s TA Score has 4 bullish TA indicator(s).
- TFX’s TA Score: 4 bullish, 5 bearish.
- TNDM’s TA Score: 4 bullish, 5 bearish.
Price Growth
TFX (@Pharmaceuticals: Other) experienced а +6.52% price change this week, while TNDM (@Medical/Nursing Services) price change was +3.81% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.59%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was +7.47%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.50%. For the same industry, the average monthly price growth was -10.64%, and the average quarterly price growth was -10.25%.
Reported Earning Dates
TFX is expected to report earnings on Nov 05, 2026.
TNDM is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+0.59% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-1.50% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
TFX and
Correlation & Price change
A.I.dvisor indicates that over the last year, TFX has been loosely correlated with A. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then A could also see price increases.
| Ticker / NAME | Correlation To TFX | 1D Price Change % | ||
|---|---|---|---|---|
| TFX | 100% | +4.74% | ||
| A - TFX | 51% Loosely correlated | -2.17% | ||
| RVTY - TFX | 47% Loosely correlated | +0.48% | ||
| TNDM - TFX | 44% Loosely correlated | +4.89% | ||
| SNN - TFX | 42% Loosely correlated | +5.64% | ||
| MTD - TFX | 42% Loosely correlated | +0.40% | ||
More | ||||
TNDM and
Correlation & Price change
A.I.dvisor indicates that over the last year, TNDM has been loosely correlated with TFX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TNDM jumps, then TFX could also see price increases.
| Ticker / NAME | Correlation To TNDM | 1D Price Change % | ||
|---|---|---|---|---|
| TNDM | 100% | +4.89% | ||
| TFX - TNDM | 45% Loosely correlated | +4.74% | ||
| GMED - TNDM | 44% Loosely correlated | +3.79% | ||
| SHC - TNDM | 40% Loosely correlated | +2.03% | ||
| AZTA - TNDM | 39% Loosely correlated | -2.04% | ||
| A - TNDM | 38% Loosely correlated | -2.17% | ||
More | ||||